Literature DB >> 28249901

Endothelin Promotes Colorectal Tumorigenesis by Activating YAP/TAZ.

Zhen Wang1,2, Peng Liu1,2, Xin Zhou1,2, Tianxiang Wang1, Xu Feng1,2, Yi-Ping Sun1, Yue Xiong3,4, Hai-Xin Yuan3, Kun-Liang Guan3,5.   

Abstract

Endothelin receptor A (ETAR) promotes tumorigenesis by stimulating cell proliferation, migration, and survival. However, the mechanism of ETAR in promoting tumor growth is largely unknown. In this study, we demonstrate that ETAR stimulates colon cell proliferation, migration, and tumorigenesis through the activation of YAP/TAZ, two transcription coactivators of the Hippo tumor suppressor pathway. Endothelin-1 treatment induced YAP/TAZ dephosphorylation, nuclear accumulation, and transcriptional activation in multiple colon cancer cells. ETAR stimulation acted via downstream G-protein Gαq/11 and Rho GTPase to suppress the Hippo pathway, thus leading to YAP/TAZ activation, which was required for ETAR-induced tumorigenesis. Overall, these results indicate a critical role of the YAP/TAZ axis in ETAR signaling. Cancer Res; 77(9); 2413-23. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28249901      PMCID: PMC6724531          DOI: 10.1158/0008-5472.CAN-16-3229

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

1.  Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.

Authors:  L Rosanò; M Varmi; D Salani; V Di Castro; F Spinella; P G Natali; A Bagnato
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

Review 2.  Emerging role of endothelin-1 in tumor angiogenesis.

Authors:  Anna Bagnato; Francesca Spinella
Journal:  Trends Endocrinol Metab       Date:  2003-01       Impact factor: 12.015

3.  Modulation of human colon tumor-stromal interactions by the endothelin system.

Authors:  G Egidy; L Juillerat-Jeanneret; J F Jeannin; P Korth; F T Bosman; F Pinet
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs.

Authors:  T F Lüscher; M Barton
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

5.  Endothelin receptor expression in colorectal cancer.

Authors:  H Ali; M Dashwood; K Dawas; M Loizidou; F Savage; I Taylor
Journal:  J Cardiovasc Pharmacol       Date:  2000-11       Impact factor: 3.105

6.  Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo.

Authors:  Laura Rosanò; Francesca Spinella; Valeriana Di Castro; Maria Rita Nicotra; Adriana Albini; Pier Giorgio Natali; Anna Bagnato
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

Review 7.  The endothelin axis: emerging role in cancer.

Authors:  Joel Nelson; Anna Bagnato; Bruno Battistini; Perry Nisen
Journal:  Nat Rev Cancer       Date:  2003-02       Impact factor: 60.716

Review 8.  Endothelin-1: a multifunctional molecule in cancer.

Authors:  K Grant; M Loizidou; I Taylor
Journal:  Br J Cancer       Date:  2003-01-27       Impact factor: 7.640

9.  Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells.

Authors:  L Peduto Eberl; R Bovey; L Juillerat-Jeanneret
Journal:  Br J Cancer       Date:  2003-03-10       Impact factor: 7.640

10.  Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism.

Authors:  E Asham; A Shankar; M Loizidou; S Fredericks; K Miller; P B Boulos; G Burnstock; I Taylor
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

View more
  26 in total

1.  Involvement of Endothelin Receptors in Peripheral Sensory Neuropathy Induced by Oxaliplatin in Mice.

Authors:  Renata Bessa Pontes; Mario Roberto Pontes Lisboa; Anamaria Falcão Pereira; Juliana Arcanjo Lino; Francisco Fábio Bezerra de Oliveira; Aline Kelly Viana de Mesquita; Bruno Wesley de Freitas Alves; Roberto César Pereira Lima-Júnior; Mariana Lima Vale
Journal:  Neurotox Res       Date:  2019-06-21       Impact factor: 3.911

2.  High expression of the transcriptional coactivator TAZ is associated with a worse prognosis and affects cell proliferation in patients with medulloblastoma.

Authors:  Hao Wang; Ji Zhou; Dong Yang; Liang Yi; Xuhui Wang; Yangqing Ou; Donghong Yang; Lunshan Xu; Minhui Xu
Journal:  Oncol Lett       Date:  2019-09-11       Impact factor: 2.967

Review 3.  Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases.

Authors:  Minyang Fu; Dandan Peng; Tianxia Lan; Yuquan Wei; Xiawei Wei
Journal:  Acta Pharm Sin B       Date:  2022-01-19       Impact factor: 14.903

Review 4.  Regulation of the Hippo pathway in cancer biology.

Authors:  Sungho Moon; So Yeon Park; Hyun Woo Park
Journal:  Cell Mol Life Sci       Date:  2018-03-30       Impact factor: 9.261

5.  Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer.

Authors:  Roberta Cianfrocca; Laura Rosanò; Piera Tocci; Rosanna Sestito; Valentina Caprara; Valeriana Di Castro; Ruggero De Maria; Anna Bagnato
Journal:  Cell Death Differ       Date:  2017-07-14       Impact factor: 15.828

Review 6.  The Role of Hippo Pathway in Cancer Stem Cell Biology.

Authors:  Jae Hyung Park; Ji Eun Shin; Hyun Woo Park
Journal:  Mol Cells       Date:  2018-02-05       Impact factor: 5.034

Review 7.  Dual roles of yes-associated protein (YAP) in colorectal cancer.

Authors:  Chunlin Ou; Zhenqiang Sun; Shen Li; Guiyuan Li; Xiayu Li; Jian Ma
Journal:  Oncotarget       Date:  2017-08-11

8.  Concurrent YAP/TAZ and SMAD signaling mediate vocal fold fibrosis.

Authors:  Ryosuke Nakamura; Nao Hiwatashi; Renjie Bing; Carina P Doyle; Ryan C Branski
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

9.  Systems analysis identifies endothelin 1 axis blockade for enhancing the anti-tumor effect of multikinase inhibitor.

Authors:  Chae Young Hwang; Su Jong Yu; Jae-Kyung Won; Sang-Min Park; Jung-Hwan Yoon; Kwang-Hyun Cho; Hyojin Noh; Soobeom Lee; Eun Ju Cho; Jeong-Hoon Lee; Kyung Bun Lee; Yoon Jun Kim; Kyung-Suk Suh
Journal:  Cancer Gene Ther       Date:  2021-08-06       Impact factor: 5.854

10.  MiR-195 suppresses the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by inhibiting YAP.

Authors:  Shuo Yu; Li Jing; Xiao-Ran Yin; Min-Cong Wang; Yi-Meng Chen; Ya Guo; Ke-Jun Nan; Li-Li Han
Journal:  Oncotarget       Date:  2017-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.